PuSH - Publication Server of Helmholtz Zentrum München: Cyclophilin A is a ligand for RAGE in thrombo-inflammation.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Seizer, P.* ; von Ungern-Sternberg, S.N.I.* ; Haug, V.* ; Dicenta, V.* ; Rosa, A.* ; Butt, E.* ; Nöthel, M.* ; Rohlfing, A.K.* ; Sigle, M.* ; Nawroth, P.P. ; Nussbaum, C.* ; Sperandio, M.* ; Kusch, C.* ; Meub, M.* ; Sauer, M.* ; Münzer, P.* ; Bieber, K.* ; Stanger, A.* ; Mack, A.F.* ; Huber, R.* ; Brand, K.* ; Lehners, M.* ; Feil, R.* ; Poso, A.* ; Krutzke, K.* ; Schäffer, T.E.* ; Nieswandt, B.* ; Borst, O.* ; May, A.E.* ; Zernecke, A.* ; Gawaz, M.* ; Heinz Mann, D.*

Cyclophilin A is a ligand for RAGE in thrombo-inflammation.

Cardiovasc. Res. 120, 385-402 (2024)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metrics
Extra information

AIMS: Cyclophilin A (CyPA) induces leukocyte recruitment and platelet activation upon release into the extracellular space. Extracellular CyPA therefore plays a critical role in immuno-inflammatory responses in tissue injury and thrombosis upon platelet activation. To date, CD147 (EMMPRIN) has been described as the primary receptor mediating extracellular effects of CyPA in platelets and leukocytes. The receptor for advanced glycation end products (RAGE) shares inflammatory and prothrombotic properties and has also been found to have similar ligands as CD147.In this study, we investigated the role of RAGE as a previously unknown interaction partner for CyPA. METHODS AND RESULTS: Confocal imaging, proximity ligation, co-immunoprecipitation, and atomic force microscopy were performed and demonstrated an interaction of CyPA with RAGE on the cell surface. Static and dynamic cell adhesion and chemotaxis assays towards extracellular CyPA using human leukocytes and leukocytes from RAGE-deficient Ager-/- mice were conducted. Inhibition of RAGE abrogated CyPA-induced effects on leukocyte adhesion and chemotaxis in vitro. Accordingly, Ager-/- mice showed reduced leukocyte recruitment and endothelial adhesion towards CyPA in vivo. In wildtype mice, we observed a downregulation of RAGE on leukocytes when endogenous extracellular CyPA was reduced. We furthermore evaluated the role of RAGE for platelet activation and thrombus formation upon CyPA stimulation. CyPA-induced activation of platelets was found to be dependent on RAGE, as inhibition of RAGE, as well as platelets from Ager-/- mice showed a diminished activation and thrombus formation upon CyPA stimulation. CyPA-induced signaling through RAGE was found to involve central signaling pathways including the adaptor protein MyD88, intracellular Ca2+ signaling, as well as NF-κB activation. CONCLUSION: We propose RAGE as a hitherto unknown receptor for CyPA mediating leukocyte as well as platelet activation. The CyPA-RAGE interaction thus represents a novel mechanism in thrombo-inflammation.

Impact Factor

Scopus SNIP

Altmetric

10.400

0.000